Two startups in the healthcare AI space, iCardio.ai and SARC MedIQ, have announced a new partnership aimed at improving how ultrasound images are analyzed and distributed. The collaboration will integrate iCardio.ai’s AI technology with SARC MedIQ’s cloud-based PACS, offering healthcare providers a more efficient and accurate way to interpret ultrasound images.
This partnership is expected to help clinicians make quicker, more precise diagnoses, particularly in the field of cardiovascular health. By using AI to enhance the interpretation of ultrasound data, both companies believe they can provide valuable tools to healthcare providers, ultimately benefiting patients.
iCardio.ai, a Los Angeles-based startup supported by Cedars-Sinai, focuses on using machine learning to improve the accuracy of cardiovascular imaging. Their AI algorithms are designed to help doctors evaluate transthoracic echocardiograms, a common test used to diagnose heart conditions.
SARC MedIQ, on the other hand, is known for its cloud-based platform that helps hospitals and clinics store, share, and analyze medical images. By incorporating iCardio.ai’s AI tools into this system, SARC MedIQ hopes to give doctors quicker, more reliable insights when evaluating patients’ ultrasound scans.
Joseph Sokol, CEO of iCardio.ai, said the partnership with SARC MedIQ is part of a larger effort to integrate AI into everyday clinical practice. “We believe our technology will help clinicians work more efficiently, improve the patient experience, and lead to better outcomes,” Sokol said.
SARC MedIQ CEO Asaad Hakeem emphasized the practical benefits for healthcare providers. “By adding AI to our PACS platform, we’re giving doctors better tools to evaluate cardiovascular conditions. This partnership will make a real difference in how quickly and accurately diagnoses can be made,” Hakeem said.